Association Between Anti-CD20 Therapies and COVID-19 Severity Among Patients With Relapsing-Remitting and Progressive Multiple Sclerosis.
Januel E, Hajage D, Labauge P, Maillart E, De Sèze J, Zephir H, Pelletier J, Guilloton L, Bensa C, Heinzlef O, Casez O, Biotti D, Bourre B, Vukusic S, Maurousset A, Berger E, Laplaud D, Lebrun-Frénay C, Dubessy AL, Branger P, Thouvenot E, Clavelou P, Sellal F, Manchon E, Moreau T, Papeix C, Tubach F, Louapre C.
Januel E, et al. Among authors: clavelou p.
JAMA Netw Open. 2023 Jun 1;6(6):e2319766. doi: 10.1001/jamanetworkopen.2023.19766.
JAMA Netw Open. 2023.
PMID: 37351881
Free PMC article.